Aptose Biosciences Cash Per Share vs. Debt To Equity
| APS Stock | CAD 0.25 0.01 3.85% |
Cash Per Share | First Reported 2010-12-31 | Previous Quarter 1.36965211 | Current Value 1.3 | Quarterly Volatility 320.42182839 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 1.04 | 1.1 |
|
|
For Aptose Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aptose Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aptose Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aptose Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aptose Biosciences over time as well as its relative position and ranking within its peers.
Aptose |
Aptose Biosciences Debt To Equity vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aptose Biosciences's current stock value. Our valuation model uses many indicators to compare Aptose Biosciences value to that of its competitors to determine the firm's financial worth. Aptose Biosciences is rated third in cash per share category among its peers. It is number one stock in debt to equity category among its peers fabricating about 7.81 of Debt To Equity per Cash Per Share. At this time, Aptose Biosciences' Cash Per Share is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Aptose Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aptose Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Aptose Debt To Equity vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Aptose Biosciences |
| = | 0.64 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Aptose Biosciences |
| = | 5.00 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Aptose Debt To Equity Comparison
Aptose Biosciences is currently under evaluation in debt to equity category among its peers.
Aptose Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Aptose Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aptose Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Aptose Biosciences' change in net profit over the period of time. It can combine multiple indicators of Aptose Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.3 M | -4.5 M | |
| Operating Income | -52.4 M | -49.7 M | |
| Net Loss | -51.2 M | -48.6 M | |
| Income Tax Expense | -693 K | -658.4 K | |
| Income Before Tax | -51.2 M | -48.6 M | |
| Total Other Income Expense Net | 1.1 M | 1.2 M | |
| Net Loss | -51.2 M | -48.6 M | |
| Net Loss | -37.6 M | -39.5 M | |
| Interest Income | 1.2 M | 577.1 K | |
| Net Interest Income | 1.2 M | 1.2 M | |
| Change To Netincome | 23.5 M | 24.7 M | |
| Net Loss | (7.58) | (7.96) | |
| Income Quality | 0.87 | 0.62 | |
| Net Income Per E B T | 0.88 | 0.79 |
Aptose Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aptose Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aptose Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aptose Biosciences' important profitability drivers and their relationship over time.
Use Aptose Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Aptose Biosciences Pair Trading
Aptose Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aptose Biosciences position
In addition to having Aptose Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials Thematic Idea Now
Financials
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
To fully project Aptose Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aptose Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aptose Biosciences' income statement, its balance sheet, and the statement of cash flows.